Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
USD 0.28
(1.32%)
USD 0.28
(1.32%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -5.89 Million USD | -130.69% |
| 2022 | -2.55 Million USD | -46.55% |
| 2021 | -1.74 Million USD | -242.08% |
| 2020 | -509.52 Thousand USD | 0.0% |
| 2018 | -586.63 Thousand USD | -187.72% |
| 2017 | -203.89 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.38 Million USD | -7.95% |
| 2024 Q2 | -1.48 Million USD | -7.06% |
| 2023 Q2 | -1.46 Million USD | 5.12% |
| 2023 Q1 | -1.54 Million USD | -108.53% |
| 2023 Q4 | -1.28 Million USD | 19.78% |
| 2023 Q3 | -1.59 Million USD | -9.11% |
| 2023 FY | -5.89 Million USD | -130.69% |
| 2022 Q3 | -821.46 Thousand USD | -132.3% |
| 2022 Q2 | -353.62 Thousand USD | 44.61% |
| 2022 Q1 | -638.39 Thousand USD | 35.42% |
| 2022 FY | -2.55 Million USD | -46.55% |
| 2022 Q4 | -740.78 Thousand USD | 9.82% |
| 2021 Q1 | -176.08 Thousand USD | 0.0% |
| 2021 FY | -1.74 Million USD | -242.08% |
| 2021 Q4 | -988.53 Thousand USD | -308.29% |
| 2021 Q3 | -242.11 Thousand USD | 28.0% |
| 2021 Q2 | -336.25 Thousand USD | -90.96% |
| 2020 FY | -509.52 Thousand USD | 0.0% |
| 2018 FY | -586.63 Thousand USD | -187.72% |
| 2017 FY | -203.89 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -155.56 Million USD | 96.212% |
| Theratechnologies Inc. | -10.62 Million USD | 44.553% |
| Safety Shot Inc | -12.18 Million USD | 51.639% |
| Cosmos Health Inc. | -21.83 Million USD | 73.009% |
| Cronos Group Inc. | -81.37 Million USD | 92.759% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 102.819% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 84.95% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 147.045% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -67.076% |
| ProPhase Labs, Inc. | -21.61 Million USD | 72.737% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -25.343% |
| Dynavax Technologies Corporation | -37.02 Million USD | 84.087% |
| Radius Health, Inc. | -3.92 Million USD | -50.124% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -134.269% |
| Alvotech | -354.86 Million USD | 98.34% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -23.135% |
| Alpha Teknova, Inc. | -35.56 Million USD | 83.431% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 96.303% |
| SCYNEXIS, Inc. | 72.66 Million USD | 108.109% |
| Harrow Health, Inc. | 580 Thousand USD | 1115.928% |
| Biofrontera Inc. | -22.67 Million USD | 74.016% |
| DURECT Corporation | -36.88 Million USD | 84.025% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -11.831% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 112.545% |
| OptiNose, Inc. | -22.74 Million USD | 74.097% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 146.646% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | 60.983% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | 5.127% |
| SIGA Technologies, Inc. | 83.62 Million USD | 107.047% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 163.148% |
| Shineco, Inc. | -17.06 Million USD | 65.473% |
| Phibro Animal Health Corporation | 53.31 Million USD | 111.052% |
| Procaps Group S.A. | 52.32 Million USD | 111.261% |
| TherapeuticsMD, Inc. | -8.52 Million USD | 30.865% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -24.398% |
| Viatris Inc. | 766.2 Million USD | 100.769% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -23.135% |
| Rockwell Medical, Inc. | -6.67 Million USD | 11.658% |
| Incannex Healthcare Limited | -30.04 Million USD | 80.386% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -12.15% |
| Tilray Brands, Inc. | -174.74 Million USD | 96.628% |
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 103.529% |
| PetIQ, Inc. | 60.01 Million USD | 109.818% |
| Silver Spike Investment Corp. | 7.34 Million USD | 180.276% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 102.348% |
| Journey Medical Corporation | -2.07 Million USD | -184.244% |
| Alimera Sciences, Inc. | -1.47 Million USD | -300.57% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | 56.729% |
| Assertio Holdings, Inc. | -243.53 Million USD | 97.58% |
| Embecta Corp. | 221.5 Million USD | 102.66% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 70.612% |
| Procaps Group, S.A. | 38.97 Million USD | 115.119% |
| PainReform Ltd. | -9.58 Million USD | 38.519% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 95.725% |
| Hempacco Co., Inc. | -8.81 Million USD | 33.134% |
| Talphera, Inc. | -16.88 Million USD | 65.111% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 106.721% |
| Alvotech | -354.86 Million USD | 98.34% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 101.616% |
| Kamada Ltd. | 10.06 Million USD | 158.549% |
| Indivior PLC | -4 Million USD | -47.31% |
| Currenc Group, Inc. | -6.64 Million USD | 11.337% |
| Evoke Pharma, Inc. | -7.43 Million USD | 20.704% |
| Flora Growth Corp. | -50.35 Million USD | 88.298% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 70.612% |
| Evolus, Inc. | -49.23 Million USD | 88.032% |
| HUTCHMED (China) Limited | 18.37 Million USD | 132.067% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 102.991% |
| Akanda Corp. | -10.05 Million USD | 41.377% |